Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This review is part of the PlexusDx Education Hub, our resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education
Full head-to-head: PlexusDx vs MEDVi →
This is an independent editorial review. PlexusDx holds no commercial relationship with Medvi or its parent company, and no affiliate links or compensation are involved.
"Medvi discount" searches tend to blend two questions: what savings mechanisms does the program offer, and who is eligible for them? This editorial review separates the two — the prepaid-bundle math and the membership structure — using what is visible on the brand’s own site. Fair-balance framing, not a buying recommendation, as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
The mechanisms Medvi uses to lower a price
Medvi (Medvi Wellness) runs as telehealth plus a 503A compounding pharmacy, and its savings come through structure rather than codes. There are essentially two levers: prepaid multi-month bundles, and flat-across-dose pricing that keeps costs from climbing as you titrate. Pricing appears only after a short health questionnaire, so confirm every figure at Medvi’s official website before relying on it.
What Medvi publishes, and who it applies to
As captured July 2026, compounded semaglutide is about $299 per month ongoing, and compounded tirzepatide about $399 per month ongoing. These rates are generally aimed at patients starting a compounded plan; they apply once clinical eligibility is confirmed through the intake evaluation, not automatically to everyone who visits.
How prepaid bundles change the math
Plan length is what changes the effective monthly rate over time. Because compounded pricing is flat across dose, prepaying does not gamble against future dose increases — the per-month figure is set by the bundle, not by how high you titrate. For anyone confident they will continue, the bundle is the most durable form of savings the compounded program offers.
Membership and the branded route
The compounded plans carry no membership fee and no separate consultation fee, so there is nothing extra to discount there. The branded Wegovy and Zepbound options are structured separately at a $99 membership plus the cost of the medication, which changes the eligibility and savings picture entirely. Medvi also lists a dissolvable GLP-1 tablet, with its price shown after intake rather than posted in advance.
What the research shows on the compound class
Discounts aside, a GLP-1 program stands on its pharmacology: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Populations and endpoints differ; individual outcomes vary.
The one variable no promotion adjusts
No first-month price or bundle changes the genetics that shape your response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) describe the metabolic terrain a compound acts on. Pathway-level and not predictive of any one compound’s effect, they are context no discount can supply.
PlexusDx delivers semaglutide and tirzepatide through its Weight Management Protocols, offered as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The value it adds is knowledge, not a markdown. The Precision Peptide Genetic Test examines 14 pathways, 49 peptides, 150+ genetic insights — the FTO, MC4R, and TCF7L2 variants behind your baseline appetite, energy-balance, and GLP-1 biology. Reading that before you start is the test before you invest approach, replacing guesswork with an informed provider conversation.
Not affiliated: PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.
Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols — semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream: take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
What discounts does Medvi offer?
The main savings lever is prepaid multi-month bundles. As captured July 2026, the ongoing rate is roughly $299 per month for compounded semaglutide and $399 per month for compounded tirzepatide. Pricing is flat across dose. Verify current figures on Medvi’s own site.
What does Medvi charge for its month-to-month pricing?
The compounded plan rate generally applies to new patients and takes effect once clinical eligibility is confirmed through the intake evaluation. It is not granted automatically to every visitor. Branded Wegovy and Zepbound options follow a separate structure with a $99 membership plus medication cost.
Do the savings depend on my dose?
No. Medvi’s compounded pricing is flat across dose, so titrating to a higher dose does not raise the monthly figure or erode a prepaid bundle’s value. The most durable saving comes from prepaying a multi-month plan, which lowers the effective monthly rate regardless of where your dose lands.
Does PlexusDx compete on discounts?
PlexusDx competes on context rather than price cuts. Its Precision Peptide Genetic Test analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 biology, paired with semaglutide and tirzepatide protocols. The differentiator is upstream genetic insight that applies no matter which program dispenses the compound.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Medvi and Mounjaro: Compounded Tirzepatide vs the Brand
MaxLife Semaglutide: How the Telehealth Program Handles It